ACXP - CIK 0001736243
Acurx Pharmaceuticals, Inc. has filed 232 documents with the SEC between 2018 and 2026. The most frequent type is insider trade (51 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| EFFECT | - | 2025-05-29 | - |
| 424B3 | - | 2025-05-29 | - |
| Annual report to shareholders | ARS | 2025-05-29 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-05-29 | - |
| Proxy statement | DEF 14A | 2025-05-29 | 2025-07-17 |
| Company correspondence | CORRESP | 2025-05-27 | - |
| SEC correspondence | UPLOAD | 2025-05-27 | - |
| IPO registration | S-1 | 2025-05-21 | - |
| D | - | 2025-05-20 | - |
| PRE 14A | - | 2025-05-19 | 2025-07-17 |
| Major company event | 8-K | 2025-05-13 | 2025-05-13 |
| Quarterly report | 10-Q | 2025-05-12 | 2025-03-31 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| EFFECT | - | 2025-04-14 | - |
| Company correspondence | CORRESP | 2025-04-10 | - |
| SEC correspondence | UPLOAD | 2025-04-10 | - |
| IPO registration | S-1 | 2025-04-04 | - |
| Major company event | 8-K | 2025-03-28 | 2025-03-25 |
| D | - | 2025-03-21 | - |
| EFFECT | - | 2025-03-19 | - |
| Major company event | 8-K | 2025-03-18 | 2025-03-18 |
| Annual report | 10-K | 2025-03-17 | 2024-12-31 |
| Employee stock plan | S-8 | 2025-03-17 | - |
| POS AM | - | 2025-03-17 | - |
| Major company event | 8-K | 2025-03-10 | 2025-03-06 |
| Prospectus supplement | 424B5 | 2025-03-10 | - |
| Major company event | 8-K | 2025-02-26 | 2025-02-24 |
| EFFECT | - | 2025-02-06 | - |
| Insider trade | 4 | 2025-02-06 | 2025-02-05 |
| Insider trade | 4 | 2025-02-06 | 2025-02-05 |
| Insider trade | 4 | 2025-02-06 | 2025-02-05 |
| Company correspondence | CORRESP | 2025-02-04 | - |
| SEC correspondence | UPLOAD | 2025-02-04 | - |
| IPO registration | S-1 | 2025-01-31 | - |
| D | - | 2025-01-17 | - |
| Insider trade | 4 | 2025-01-08 | 2025-01-06 |
| Insider trade | 4 | 2025-01-08 | 2025-01-06 |
| Insider trade | 4 | 2025-01-08 | 2025-01-06 |
| Insider trade | 4 | 2025-01-08 | 2025-01-06 |
| Insider trade | 4 | 2025-01-08 | 2025-01-06 |
| Insider trade | 4 | 2025-01-08 | 2025-01-06 |
| Prospectus supplement | 424B5 | 2025-01-07 | - |
| Major company event | 8-K | 2025-01-07 | 2025-01-06 |
| 424B3 | - | 2025-01-06 | - |
| Major company event | 8-K | 2024-11-13 | 2024-11-13 |
| Quarterly report | 10-Q | 2024-11-12 | 2024-09-30 |
| Major company event | 8-K | 2024-08-09 | 2024-08-09 |
| Quarterly report | 10-Q | 2024-08-08 | 2024-06-30 |
| Insider trade | 4 | 2024-06-18 | 2024-06-17 |
| Insider trade | 4 | 2024-06-18 | 2024-06-17 |